Two Air India Pilots Suspended After Failing Preliminary Drug Tests Post-Flight Incident

On August 4, 2026, an Air India flight traveling from Phuket to Delhi experienced a significant in-flight incident involving an altitude drop. This event raised immediate concerns about flight safety and pilot fitness.

In the aftermath, Air India faced mounting public and regulatory scrutiny. The airline responded by announcing new health and substance screening protocols for its pilots, aiming to restore confidence in its operations and ensure passenger safety.

Beginning August 13, Air India introduced mandatory drug and psychoactive substance testing for all pilots, according to India Today and Amar Ujala. The move came after a pilot was previously found positive for marijuana, leading to broader questions about substance abuse in the industry.

Within days, 300 to 400 pilots from both Air India and Air India Express underwent initial screening. By August 17, NDTV India and other outlets reported that two more pilots had failed the initial 'non-negative' drug tests. Both were immediately removed from active duty as a precaution while their confirmatory test results were pending.

This rapid escalation pushed the Directorate General of Civil Aviation (DGCA) to consider stricter anti-doping rules for all commercial pilots, as reported by Business Line on August 19. The Federation of Indian Pilots urged regulators to increase random drug testing from 10 percent to at least 25 percent of pilots each year, and to explore saliva-based screening methods for quicker results.

Other airlines, such as IndiGo, highlighted their own higher testing rates, with their CEO telling Business Line that 20 percent of their pilots are tested annually, exceeding the minimum regulatory requirements.

As of August 25, the two Air India pilots who failed the initial tests remain off duty while confirmatory test results are awaited, according to NDTV India and Indian Express. The government is weighing annual or even 100 percent random drug testing for all commercial pilots, signaling a likely overhaul of existing protocols.

The airline continues its mass screening program, and regulatory changes are expected soon as the Ministry of Civil Aviation and DGCA review current policies in response to these incidents.

The main questions are whether confirmatory tests will uphold the initial non-negative results for the suspended pilots, and how quickly the government will implement stricter drug testing rules for all pilots. Changes to testing frequency and methods could reshape safety procedures across India's aviation sector.